Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
NCT06167408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2023-12-12
Summary
The objective of this retrospective study was to investigate the factors influencing in-hospital relapse during acute episodes of pemphigus, an autoimmune blistering disease characterized by self-antibodies targeting desmogleins. The study included 96 pemphigus patients hospitalized in China between January 2014 and December 2020. The primary questions addressed by the study were:
What are the risk factors associated with in-hospital relapse during acute episodes of pemphigus? Participants in the study underwent a retrospective analysis using univariate and multivariate Cox regression analysis to identify and understand the various risk factors contributing to in-hospital relapse. This research aimed to contribute valuable insights into the factors influencing the course of pemphigus, providing crucial information for better management and treatment strategies.
Conditions
- Pemphigus Vulgaris
Sponsors & Collaborators
-
First Affiliated Hospital of Chongqing Medical University
lead OTHER
Eligibility
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-06-01
- Completion
- 2022-06-01
Countries
- China
Study Locations
More Related Trials
-
Coagulation Activation in Patients With Pemphigus
NCT06285435 ·Status: NOT_YET_RECRUITING
-
Serum IL-21 Levels in Patients With Pemphigus Vulgaris
NCT03177213 ·Status: UNKNOWN
-
Identification of Vulnerability Factors in the Course of Pemphigus Patients
NCT02237313 ·Status: COMPLETED ·Phase: NA
-
Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.
NCT06863454 ·Status: NOT_YET_RECRUITING
-
Clinical Research on Advanced Warning Factors Of Respiratory Injury in Dermatomyositis
NCT04747652 ·Status: UNKNOWN
-
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.
NCT07188402 ·Status: COMPLETED
-
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
NCT05284929 ·Status: UNKNOWN
-
Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study
NCT06261086 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
NCT04319120 ·Status: RECRUITING
-
Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
NCT03262922 ·Status: COMPLETED
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
NCT01313923 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Determinants of Chronic Inflammatory Skin Disease Trajectories
NCT05928169 ·Status: RECRUITING
-
Questionnaire and Laboratory Data on Vitiligo Vulgaris
NCT01206374 ·Status: COMPLETED
-
The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors
NCT04469582 ·Status: UNKNOWN
-
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627 ·Status: RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
NCT04356014 ·Status: UNKNOWN
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
NCT07276425 ·Status: RECRUITING
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3